Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+27.0%
5Y CAGR-4.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+27.0%/yr
Annual compound
5Y CAGR
-4.8%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 19.61% |
| 2024 | -324.76% |
| 2023 | 126.93% |
| 2022 | 9.56% |
| 2021 | -48.35% |
| 2020 | 25.11% |
| 2019 | -29.42% |
| 2018 | -3592.21% |
| 2017 | 105.33% |
| 2016 | -86.56% |